Do Covariates Change the Estimand?

References

• Akacha, M., Bretz, F., and Ruberg, S. (2017), “Estimands in Clinical Trials—Broadening the Perspective,” Statistics in Medicine, 36, 5–19. DOI:10.1002/sim.7033.
   PubMed Web of Science ®Google Scholar
• Bornkamp, B., and Bermann, G. (2019), “Estimating the Treatment Effect in a Subgroup Defined by an Early Post-Baseline Biomarker Measurement in Randomized Clinical Trials With Time-to-Event Endpoint,” Statistics in Biopharmaceutical Research, 1–17. DOI:10.1080/19466315.2019.1575280.
   Web of Science ®Google Scholar
• Box, G. E. (1979), “Robustness in the Strategy of Scientific Model Building,” in Robustness in Statistics, eds. R. L. Launer and G. N. Wilkinson, New York: Academic Press, pp. 201–236.
   Google Scholar
• Cai, T., Tian, L., Wong, P. H., and Wei, L. (2010), “Analysis of Randomized Comparative Clinical Trial Data for Personalized Treatment Selections,” Biostatistics, 12, 270–282. DOI:10.1093/biostatistics/kxq060.
   PubMed Web of Science ®Google Scholar
• Ellenberg, S. S., and Ellenberg, J. H. (2019), “Proceedings of the University of Pennsylvania 11th Annual Conference on Statistical Issues in Clinical Trials: Estimands, Missing Data and Sensitivity Analysis,” Clinical Trials, DOI:10.1177/1740774519853569.
   PubMed Web of Science ®Google Scholar
• Federal Food, Drug, and Cosmetic Act, as amended (2019), available at https://legcounsel.house.gov/Comps/FederalFood,Drug,AndCosmeticAct.pdf.
   Google Scholar
• Gruber, S., and Van der Laan, M. (2018), “Targeted Maximum Likelihood Estimation,” available at https://cran.r-project.org/web/packages/tmle/tmle.pdf.
   Google Scholar
• Hauck, W. W., Anderson, S., and Marcus, S. M. (1998), “Should We Adjust for Covariates in Nonlinear Regression Analyses of Randomized Trials?,” Controlled Clinical Trials, 19, 249–256. DOI:10.1016/S0197-2456(97)00147-5.
   PubMedGoogle Scholar
• International Council for Harmonization (2017), “Statistical Principles for Clinical Trials,” available at https://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html.
   Google Scholar
• Künzel, S. R., Sekhon, J. S., Bickel, P. J., and Yu, B. (2017), “Meta-Learners for Estimating Heterogeneous Treatment Effects Using Machine Learning,” arXiv no. 1706.03461.
   Google Scholar
• Lehmann, E. L., and Casella, G. (2006), Theory of Point Estimation, New York: Springer.
   Google Scholar
• Luedtke, A. R., and van der Laan, M. J. (2016), “Super-Learning of an Optimal Dynamic Treatment Rule,” The International Journal of Biostatistics, 12, 305–332. DOI:10.1515/ijb-2015-0052.
   PubMedGoogle Scholar
• Mehrotra, D. V. (2019), “A Note on the Draft International Council for Harmonisation Guidance on Estimands and Sensitivity Analysis,” Clinical Trials. DOI:10.1177/1740774519844259.
   PubMed Web of Science ®Google Scholar
• Permutt, T. (2003), “Adjustment for Covariates,” in Encyclopedia of Biopharmaceutical Statistics, ed. S.-C. Chow, London: Informa Health Care, pp. 18–21.
   Google Scholar
• Permutt, T. (2018), “Effects in Adherent Subjects,” Statistics in Biopharmaceutical Research, 10, 233–235. DOI:10.1080/19466315.2018.1458650.
   Web of Science ®Google Scholar
• Permutt, T. (2019a), “Defining Treatment Effects: A Regulatory Perspective,” Clinical Trials. DOI:10.1177/1740774519830358.
   PubMed Web of Science ®Google Scholar
• Permutt, T. (2019b), “Treatment Effects, Comparisons, and Randomization,” Statistics in Biopharmaceutical Research, 1–9 (just-accepted). DOI:10.1080/19466315.2019.1624192.
   Web of Science ®Google Scholar
• Rao, J. N., and Molina, I. (2015), Small Area Estimation, New York: Wiley.
   Google Scholar
• Rubin, D. B. (1974), “Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies,” Journal of Educational Psychology, 66, 688. DOI:10.1037/h0037350.
   Web of Science ®Google Scholar
• Rubin, D. B., and van der Laan, M. J. (2012), “Statistical Issues and Limitations in Personalized Medicine Research With Clinical Trials,” The International Journal of Biostatistics, 8, 1–20. DOI:10.1515/1557-4679.1423.
   Google Scholar
• Scharfstein, D. O. (2019), “A Constructive Critique of the draft ICH E9 Addendum,” Clinical Trials, DOI:10.1177/1740774519853566.
   PubMed Web of Science ®Google Scholar
• Tsiatis, A. A., Davidian, M., Zhang, M., and Lu, X. (2008), “Covariate Adjustment for Two-Sample Treatment Comparisons in Randomized Clinical Trials: A Principled Yet Flexible Approach,” Statistics in Medicine, 27, 4658–4677. DOI:10.1002/sim.3113.
   PubMed Web of Science ®Google Scholar
• Van der Laan, M. J., and Rose, S. (2011), Targeted Learning: Causal Inference for Observational and Experimental Data, New York: Springer.
   Google Scholar
• Zhang, B., Tsiatis, A. A., Laber, E. B., and Davidian, M. (2012), “A Robust Method for Estimating Optimal Treatment Regimes,” Biometrics, 68, 1010–1018. DOI:10.1111/j.1541-0420.2012.01763.x.
   PubMed Web of Science ®Google Scholar